Arsenal Biosciences
Oncology
0 open roles Oncology South San Francisco, United States 127 employees $631M raised Est. 2019
NVentures
ARCH Venture Partners
Luma Group
Milky Way Investments Group
Regeneron Ventures
Parker Institute for Cancer Immunotherapy
About Arsenal Biosciences
A clinical-stage programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Arsenal Biosciences is listed on Rocketlist with 0 active roles. The company is categorized as Oncology in BioTech. Arsenal Biosciences is at Series C stage, with a B2B business model, headquartered in South San Francisco, United States. Arsenal Biosciences was founded in 2019 and has 127 employees. Arsenal Biosciences has raised $631M. Active roles are refreshed daily from public hiring sources.